首页> 美国卫生研究院文献>Drug Design Development and Therapy >5-(Thiophen-2-yl)-134-thiadiazole derivatives: synthesis molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents
【2h】

5-(Thiophen-2-yl)-134-thiadiazole derivatives: synthesis molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents

机译:5-(噻吩-2-基)-134-噻二唑衍生物:合成分子对接和体外细胞毒性评估作为潜在的抗癌药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundNowadays, cancer is an important public health problem in all countries. Limitations of current chemotherapy for neoplastic diseases such as severe adverse reactions and tumor resistance to the chemotherapeutic drugs have been led to a temptation for focusing on the discovery and development of new compounds with potential anticancer activity. The importance of thiophene and thiadiazole rings as scaffolds present in a wide range of therapeutic agents has been well reported and has driven the synthesis of a large number of novel antitumor agents.
机译:背景技术如今,癌症已成为所有国家的重要公共卫生问题。对于诸如严重不良反应和肿瘤对化学治疗药物的耐药性之类的肿瘤疾病的当前化学疗法的局限性导致人们倾向于集中于发现和开发具有潜在抗癌活性的新化合物。噻吩和噻二唑环作为广泛存在于多种治疗剂中的支架的重要性已得到充分报道,并已推动了许多新型抗肿瘤剂的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号